The results of numerous preclinical and clinical studies suggest that cell transplantation therapy may promote functional recovery after neurological disorders including cerebral infarct. A variety of cell types including embryonic stem cells, bone marrow-derived mesenchymal stem cells, induced pluripotent stem cells, and NSCs have demonstrated efficacy in ischemic stroke animal models [3]. Of these cell types, the use of NSCs is most attractive as they are minimally immunogenic [4]. NSCs can also differentiate into neurons, astrocytes, oligodendrocytes, and even endothelium which constitute most of the cerebral cell types affected by ischemic insult [5-7].
The results of numerous preclinical and clinical studies suggest that cell transplantation therapy may promote functional recovery after neurological disorders including cerebral infarct. A variety of cell types including embryonic stem cells, bone marrow-derived mesenchymal stem cells, induced pluripotent stem cells, and NSCs have demonstrated efficacy in ischemic stroke animal models [3]. Of these cell types, the use of NSCs is most attractive as they are minimally immunogenic [4]. NSCs can also differentiate into neurons, astrocytes, oligodendrocytes, and even endothelium which constitute most of the cerebral cell types affected by ischemic insult [5-7].
การแปล กรุณารอสักครู่..